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Abstract 
The peritoneum defines a confined microenvironment, which is stable under 
normal conditions, but is exposed to the damaging effect of infections, 
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surgical injuries, and other neoplastic and non-neoplastic events. Its response 
to damage includes the recruitment, proliferation and activation of a variety of 
haematopoietic and stromal cells. In physiologic conditions, effective 
responses to injuries are organized, inflammatory triggers are eliminated, 
inflammation quickly abates, and the normal tissue architecture is restored. 
However, if inflammatory triggers are not cleared, fibrosis or scarring occur 
and impaired tissue function ultimately leads to organ failure. Autoimmune 
serositis is characterized by the persistence of self-antigens and a relapsing 
clinical pattern. Peritoneal carcinomatosis and endometriosis are 
characterized by the persistence of cancer cells or ectopic endometrial cells in 
the peritoneal cavity. Some of the molecular signals orchestrating the 
recruitment of inflammatory cells in the peritoneum have been identified in the 
last few years. Alternative activation of peritoneal macrophages was shown to 
guide angiogenesis and fibrosis, and could represent a novel target for 
molecular intervention. This review summarizes current knowledge of the 
alterations to the immune response in the peritoneal environment, highlighting 
the ambiguous role played by persistently activated reparative macrophages 
in the pathogenesis of common human diseases. 
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 The peritoneum: a peculiar (and crowded) microenvironment 
The mesothelial membrane that lines the abdominal cavity is situated directly 
beneath the abdominal musculature (rectus abdominis and transversus 
abdominis) and comprises a thin layer of loose connective tissue covered by a 
single layer of mesothelial cells [1]. The latter is referred to as the peritoneum 
and collectively, the connective tissue and peritoneum are referred to as the 
serosa (Figure 1). Mesothelial cells are squamous cells of mesodermal origin, 
characterized by apical microvilli, fragility and high turnover [1,2]. The 
peritoneal membrane contributes to the protection of the abdominal cavity, 
providing an environment that facilitates response to mechanical stresses and 
in which organs are kept separate and slide on one another. Two layers of 
peritoneum line the abdomen: the parietal layer lines the abdominal wall, 
while the visceral layer lines the abdominal viscera. The narrow space within 
these two layers is referred to as the peritoneal cavity [2]. The peritoneum 
provides a route for entry of nerves, blood and lymphatic vessels. Pathogens 
and bacterial toxins are also readily absorbed and cause inflammation [3]. 
The peritoneum contains the peritoneal fluid (PF), continuously produced by 
mesothelial cells as a plasma transudate, and reabsorbed through the large 
surface area of the peritoneum. The PF facilitates frictionless movement of 
abdominal organs (e.g. during peristalsis), permits the exchange of nutrients, 
removes pathogens and cells ascending from the female genital tract, and 
allows reparative events [4]. The PF is in equilibrium with the plasma, even if 
it does not contain large molecules. The PF is highly fibrinolytic, an activity 
that may restrict the formation of adhesions in response to injury (see below).  
Growth factors, nutrients, cytokines and chemokines, as well as leukocytes, 
are continuously exchanged between the PF and the blood. Monocytes and 
macrophages account for 50-90% of the leukocytes, and in normal conditions 
dispose of debris and pathogens [5]. Regulation of the composition of the 
peritoneal extracellular matrix (ECM) and of the receptors involved in matrix 
sensing (integrins and the α5β1 receptor in particular) shapes the mobilization 
of leukocytes from the bone marrow to the blood. Actively generated signals 
promote their active recruitment to the peritoneal cavity, in normal resting 
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conditions and upon induction of local acute inflammation [6, 7]. Matrix 
remodelling and clearance of apoptotic cells and other particulate substrates 
modulate the function of peritoneal macrophages, committing them to an 
alternatively activated state with the upregulation of chemokine receptors 
such as CXCR4 [8]. 
The second most represented cells are B1 lymphocytes. These are a source 
of natural antibodies (IgM and IgA, in particular) with broad specificity and low 
antigen affinity [9]. Although initial reports suggested a constitutive 
spontaneous production of antibodies by B1 lymphocytes, further evidence 
points towards a requirement for an activation signal for IgM production [10], 
followed by the relocation of these cells in secondary lymphoid organs [11]. 
B1 cells contribute to the removal of microbes early after infection and 
facilitate the switch from innate to adaptive immunity. Their survival in 
physiological conditions is tightly regulated, via a mechanism dependent on 
the inhibitory FcγRIIb receptor and modulated by B-cell activating factor 
(BAFF) and its receptor [12, 13]. T lymphocytes, dendritic cells, neutrophils, 
natural killer cells and mast cells are also represented [14]. 
The peritoneum is exposed to a variety of stressing events, including surgical 
or accidental injuries as well as viral and bacterial infection. Advanced liver or 
kidney failure cause the accumulation of PF, that upon infection leads to 
microbial peritonitis [15]. Damage-associated and pathogen-associated 
molecular patterns (DAMPs and PAMPs, released by dying cells and by 
invading microorganisms respectively) induce the recruitment, the proliferation 
and the activation of haematopoietic and non-haematopoietic cells, which 
together contribute to repair the tissue [16, 17]. The response leads to the 
elimination of the stimuli from the peritoneal cavity. In this case, inflammation 
abates and the tissue heals (Figure 2A). However, if the triggers persist, 
pathological fibrosis or scarring develop, impairing normal tissue function and 
leading to organ failure [18, 19] (Figure 2B). 
Conditions in which inflammatory triggers are eliminated: healing vs. 
fibrosis 
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The recognition of microbes in the peritoneal cavity induces an inflammatory 
response, either localized or widespread. Archetypal inflammation is followed 
by oedema and production of fibrogenic exudates, with the formation of 
fibrotic tissue in the form of adhesions between serosal surfaces [20-22]. 
Peritoneal repair involves the proliferation of the normally quiescent 
mesothelial cells in response to inflammatory signals released by bystander 
injured cells and by inflammatory leukocytes in the early phases. Later on, 
angiogenesis, cell migration and regulated turnover of the ECM predominate 
[23, 24]. Repair occurs diffusely through the injured mesothelial membrane 
and not from the wound edges, as in the case of epithelial organs and tissues. 
The integrity of the peritoneum is usually soon restored, possibly because of 
the combined action of mesothelial cells migrating from the wound edges and 
detaching from the opposing surfaces and from distant sites [24]. Other 
precursors from the bone marrow may also float in the peritoneal fluid and 
adhere to the denuded surface of the serosa [25]. In all cases, the PF, now a 
high-protein exudate containing fibrin, histamines, monocytes, granulocytes, 
macrophages and mesothelial cells, guides the reparative process [5]. The 
fluid coagulates within few hours, yielding fibrinous bands between 
corresponding surfaces maintaining their contact. Later, neutrophils entangle 
in fibrin strands and macrophages cover the wound.  
In response to injury, macrophages increase their phagocytic activity, 
generate reactive oxygen species, an recruit and activate additional 
mesothelial cells and fibroblasts to prompt repair [26-28]. Adhesions are 
formed within 72 hours. Fibrinolysis counteracts this phenomenon and allows 
healing of the tissue. The plasticity of mesothelial cells is reflected by the 
“mesothelial-mesenchymal transition” phenomenon [29]. This results in a 
TGF-β-dependent formation of motile fibroblastoid cells that up-regulate alpha 
smooth muscle actin (α-SMA) and express type I collagen [24]. Mesothelial-
derived myofibroblasts may play a role in the accumulation of ECM proteins 
and in the contraction of the repairing tissue, thus ensuring effective wound 
healing or prompting fibrosis [23, 30-34] (serosal adhesions in particular). The 
peritoneal microenvironments contain many components essential for healing, 
including collagens I and III, fibronectin, glycoproteins, fibroblasts, 
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macrophages, and blood and lymphatic vessels [30, 35]. The essential role of 
locally generated pentraxins, such as the prototypical long pentraxin PTX3, in 
stabilizing the provisional matrix and prompting effective healing has been 
recently demonstrated in various tissues [36-38]. 
Disruption of matrix assembly jeopardizes healing and/or favours adhesion 
formation [39-41]. It is known that hepatic fibrosis and even cirrhosis are 
potentially reversible if the underlying cause is removed [42]. Thus, at least in 
the liver, fibrosis is not the final outcome of a process leading to scar 
formation, but an actively maintained condition reflecting a maladaptive and 
sustained inflammatory response. This concept is relevant for the biology of 
peritoneal diseases.  
Conditions in which inflammatory triggers are not eliminated: 
autoimmune serositis, cancer and endometriosis 
When the inflammatory triggers are not eliminated, peritoneal inflammation 
does not abate, and leads to scar formation, impaired tissue function and 
eventually to organ failure. Examples comprise the response to self-antigens 
that induce autoimmune serositis in a transient-recurrent manner, or the 
response to neoplastic or ectopic cells, the main players of peritoneal 
carcinomatosis and endometriosis respectively. 
Autoimmune serositis 
Healthy individuals do not usually mount sustained adaptive responses to 
their own antigens; transient responses to damaged self-tissues do occur, but 
rarely cause tissue damage. Although self-tolerance is the rule, autoimmunity 
occurs in predisposed individuals. Consequently, tissue repair takes place 
and fibroplasia and granulation tissue are formed. Activated myofibroblasts 
produce a provisional ECM by excreting collagens and fibronectin. Because 
autoantigens cannot be eliminated, they elicit cycles of injury and repair and 
eventually overcome the ability of fibrinolysis to prevent fibrosis within the 
peritoneum. 
Serositis refers to an inflammation of the lining of the lung, heart, or abdomen 
and peritoneum. Recurrent serositis is associated with autoimmune diseases 
such as Crohn’s disease, familial mediterranean fever (FMF) and systemic 
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lupus erythematosus (SLE). Crohn’s disease is a characteristically segmental 
inflammatory bowel disease with extra-intestinal manifestations and immune-
mediated features. The peritoneal serosa is usually spared, while the 
abdominal serosa is frequently involved. Rarely, inflammation of the lining of 
the lung or of the lung sacs occurs [43]. 
FMF is an auto-inflammatory disease associated with mutations in the MEFV 
gene that encodes the pyrin innate immunity regulator. In FMF, unrestrained 
production of IL-1β causes fever and polyserositis. Emotional factors, trauma 
and infection trigger both serositis and musculoskeletal pain. Menstruation 
plays an important role [44]; the pathophysiology underlying this relationship, 
and the role of blood accumulating in the peritoneal cavity as an inflammatory 
trigger (see below) are still unclear [45]. 
SLE is the prototypic autoimmune systemic disease, with antibodies specific 
for ubiquitous and abundant antigens, such as chromatin and proteins of the 
pre-mRNA splicing machinery. Inflammation of the peritoneum and the 
pericardium or pleuritis are frequent. Inflammatory fluid contains high levels of 
DNA and low levels of complement, suggesting that SLE serositis depends on 
deposition of immunocomplexes [46]. Inflammation abates with scar formation 
every time autoantigens are transiently targeted, and consequently the 
disease is exacerbated. Early appearance of serositis can be used to predict 
the risk of SLE development [47]. 
Peritoneal cancers and endometriosis 
Tumours have been described as ‘wounds that do not heal’. The signals 
promoting cell survival, proliferation and movement, as well as those 
favouring neo-angiogenesis, are useful for tissue repair. Conversely, they 
might be essential for the survival, growth and spreading of neoplastic cells. 
Most peritoneal tumors derive from extraperitoneal lesions. Primary peritoneal 
neoplasms of serosal origin are rare and usually of mesenchymal origin, 
deriving either from mesothelial cells (mesothelioma) or from adipose 
precursor cells in the stroma [48]. Mesothelioma is correlated to asbestos 
exposure, and affects all serosas [49]. Calcification and ascites formation are 
frequent [48]. Peritoneal carcinomatosis depends on the diffusion of cells from 
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carcinomas of the stomach, colon, ovaries, bladder, Fallopian tubes or 
pancreas [50]. Growing tumours eventually infiltrate structures contacting the 
visceral layer of the peritoneum and neoplastic cells detach and diffuse in the 
peritoneal cavity. Their fate within the peritoneal cavity has not been so far 
thoroughly investigated. Most cells die, but at least a fraction survive, attach to 
the mesothelium and – if the environment is permissive – yield metastatic 
lesions. 
Islands of vascularized endometrial tissue at ectopic sites define 
endometriosis. During menstruation, the menstrual effluent is partially 
regurgitated through the Fallopian tubes into the peritoneal cavity. This is 
supposed to be necessary for endometriosis establishment [51]. It is not 
sufficient, though, since retrograde menstruation is common in healthy women 
[52]. The events that influence the ability of shed endometrium to survive, to 
attach and infiltrate the peritoneum and to recruit vessels have been only 
partially elucidated. 
Peritoneal inflammation in endometriosis and carcinomatosis 
Chronic inflammation, with persistent repair and eventual remodelling of the 
peritoneum, is a common feature of autoimmune serositis, cancer and 
endometriosis. Remodelling refers to the reorganization or renovation of the 
existing tissue, and sustains tissue alteration, diffusion, survival, spreading, 
and organization of ectopic and inflammatory tissue. It is achieved through the 
degradation and resynthesis of ECM components, orchestrated and guided by 
extracellular proteolysis and fibroblast activation [53]. Matrix 
metalloproteinases degrade ECM components and produce biologically active 
peptides, create space for cell migration and modify intercellular junctions, 
regulating the overall tissue architecture [54]. 
ECM dynamics result in altered synthesis or degradation of ECM 
components, influencing its architecture. ECM components are laid down, 
cross-linked and organized together via covalent and non-covalent 
modifications, determining the outcome of the interaction with 
stromal/inflammatory cells [55-58]. Thus the expression and function of ECM-
modifying enzymes and stromal/inflammatory cells influence the 
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dissemination of ectopic or transformed cells, their diffusion in the peritoneal 
cavity and attachment to the serosa, specifically sustaining lesion 
vascularization. Each of these steps is discussed below. 
Tissue remodelling by immune cells 
Epidemiological studies and experimental findings support a role for chronic 
inflammation in fostering cancer [59, 60] and endometriosis [61, 62]. 
Recruited leukocytes possibly remodel the tissue, favouring tumour 
progression by supplying growth factors to sustain cell proliferation, survival 
factors to overcome cell death, and angiogenic factors and extracellular 
matrix-remodeling enzymes to foster angiogenesis [63]. Tumour-associated 
macrophages (TAMs) release proteases, cytokines and chemokines such as 
CCL2 and CXCL8, that promote tissue remodelling [64-68], as well as growth 
factors such as TGFβ, VEGFA, VEGFC, EGF and thymidine phosphorylase 
(TP), that promote angiogenesis and lymphangiogenesis under hypoxic 
conditions [69, 70]. Immune cells are crucial in the growth and vascularization 
of endometriotic lesions [71]. The presence of ectopic tissue in the peritoneal 
cavity is associated with overproduction of prostaglandins, cytokines and 
chemokines by infiltrating leukocytes [51]. Macrophages are a major source of 
inflammatory molecules that modify the peritoneal environment. They 
consistently infiltrate ectopic endometrial lesions, which in the absence of 
macrophages fail to establish and to grow in animal models [72, 73]. Thus the 
failure of endometriotic lesion establishment in these systems underscores 
the importance of leukocyte infiltration in the lesions. 
Diffusion and spreading 
Peritoneal colorectal cancer dissemination was originally thought to follow a 
random pattern. However, it is now clear that lesions develop at preferential 
sites following the PF hydrodynamics and gravity. In contrast, in the absence 
of ascites, cancer cells are restricted in motion and implant nearer to the 
primary site [74, 75]. The neoplastic spreading in the peritoneum often 
depends on passive intraperitoneal seeding of cells exfoliated from exposed 
primary intraperitoneal tumors. Neoplastic cells detach spontaneously from 
the abdominal masses because of high interstitial fluid pressure, contraction 
of the interstitial matrix, increased osmotic pressure and down-regulation of 
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the molecules that ensure cell-to-cell adhesion within the primary neoplastic 
lesion [76]. Shed neoplastic cells are transported in the PF along mesentery 
and ligaments towards contiguous or non-contiguous organs. Malignant 
lesions accumulate preferentially where the fluid is deposited, including the 
liver surface (because of the negative pressure under the diaphragm) or 
ovaries (located in the cul-de-sac of the peritoneum). Antineoplastic 
treatments can also paradoxically favor the access of cancer cells to the 
peritoneal cavity. Surgery in particular facilitates the dissemination of tumors 
into the peritoneal cavity, with neoplastic cells being released from transected 
lymphatic vessels and from tumour-contaminated blood from the neoplastic 
specimen [77, 78]. 
Cancer cells also diffuse from primary lesions via lymphatic and blood 
vessels, which allow direct access to the sub-mesothelial space. 
Dissemination via lymphatic vessels occurs from regional to central nodes, 
and haematogenous spread occurs via the mesenteric arteries. Accordingly, 
regions of the peritoneum enriched in lymphatics are early sites of metastasis. 
Peritoneal lesions derived from various distant cancers, including mammary 
and lung carcinoma and malignant melanoma, have been described [79]. 
During menstruation, erythrocytes and leucocytes accumulate in the 
peritoneal fluid of most women [80-82]. Haemolysis and/or defective 
clearance of dying red blood cells results in iron release, with production of a 
wide variety of damaging free radical species by the Fenton reaction, with lipid 
peroxidation, protein and DNA damage. These signals favour adherence to 
the peritoneal wall of the endometrial fragments [71, 83-87]. Peritoneal 
macrophages are professional phagocytes, whose primary role is the 
clearance of particulate debris, including apoptotic leukocytes and senescent 
red blood cells. When their clearance ability is overwhelmed, and in the 
presence of an excess of free radicals, peripheral macrophages generate, 
through NF-ߢB, multiple inflammatory signals supporting recruitment of further 
phagocytes at the site. These events might be specifically involved in the 
persisting inflammatory status of endometriotic lesions, in which the 
endometrial tissue still responds to normal hormonal signals, but menstrual 
blood cannot be eliminated by the normal process of physiological shedding 
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[84, 88-93] . Generally, oxidative injury occurs when continued delivery of iron 
to the peritoneal macrophages is associated with inhibition of iron storage in 
ferritin [62, 84, 94-97] Macrophages also serve as a source of nitric oxide 
(NO) [84]. NO produced in abundance by the inducible form of NO synthase, 
induced by oxidant-sensitive transcription factors like NF-ߢB [98], exacerbates 
endometriosis [99, 100]. The exfoliated cancer or ectopic cells must then: i) 
survive in the peritoneal environment; ii) adhere to the surface of the serosa; 
iii) migrate into the sub-mesothelial space and iv) attach firmly via integrins to 
the mesothelial basement membrane. At later stages, cancer cells express 
matrix proteinases that disrupt the peritoneal blood barrier and invade the 
sub-peritoneal tissue. Angiogenesis is crucial for the further growth of 
established lesions [73]. 
Attachment/Dissemination.  
Peritoneal cancer dissemination has been considered a random process for 
many years. However, lesions develop at preferential sites, possibly because 
of the pattern of PF flow and sites of stasis, which in turn are influenced by 
physical forces such as fluid hydrodynamics and gravity [74, 75]. In contrast, 
in the absence of ascites, cancer cells are restricted in motion and so implant 
near to the primary site. Peritoneal dissemination of cancer cells involves 
several steps: detachment of cells from the primary tumour, survival in the 
abdominal cavity, attachment to the peritoneum, invasion of the subperitoneal 
space and proliferation with angiogenesis. Various molecular events must 
thus cooperate for cancer cells to efficiently attach and adhere to the 
peritoneal lining, but limited information is available [101]. 
This is probably also the case for endometriotic lesions, even if endometrial 
fragments and not isolated endometrial cells adhere to the serosa. In vitro 
models have shown that the process is short and that the active participation 
of mesothelial cells is necessary [102, 103]. After adhesion, the endometrial 
tissue invades the underlying mesothelial basement membrane without the 
need for its physical disruption, as initially thought. It is a prerequisite for the 
organization of the ectopic endometrial cells in three-dimensional cysts [102]. 
Invasion per se is not sufficient: angiogenesis is necessary for the 
establishment of endometriotic lesions.  
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Ascites reflects the accumulation of protein-rich exudate in the abdominal 
cavity, and represents a presenting feature of advanced-stage ovarian cancer 
or a relatively late event in carcinomatosis associated with other neoplasm. 
Accumulation of PF depends on enhanced filtration and/or decreased 
drainage or clearance, because of:  i) hindrance of lymphatic vessels by 
metastatic cells ii) VEGF-dependent increased permeability of the 
peritoneum-associated vasculature iii)  hypoproteinaemia facilitating fluid 
movement to the peritoneal cavity iv) hepatic involvement with portal 
hypertension. Most PF accumulating in the peritoneal cavity depends on that 
part of peritoneal serosa which is not directly infiltrated by neoplastic cells [78] 
Angiogenesis 
The formation of new blood vessels in adult tissues (neoangiogenesis) is 
critical for the establishment of benign or malignant lesions in the peritoneal 
cavity. As the lesion burden grows, endothelial cells are recruited to form new 
blood vessels to meet the increased metabolic demands. This process 
depends on inflammatory cells and specifically on the ability to attract 
“reparative” macrophages that release growth factors and matrix-remodelling 
enzymes, promote neoangiogenesis, and might play a role in the ability of 
endometriotic and neoplastic cells to yield peritoneal lesions. This general 
paradigm well agrees with data obtained in humans and in experimental 
models of peritoneal disease, including ovarian cancer [50, 104] and 
endometriosis [72, 73].  
Carcinoma cells release a prototypic DAMP/alarmin, HMGB1, which guides 
tissue regeneration and supports neo-angiogenesis. Exogenous HMGB1 
accelerates leukocyte recruitment, macrophage infiltration, tumour growth and 
neoangiogenesis in experimental models [105-107]. Chemotherapeutic 
agents in animal models induce HMGB1 in the peritoneal cavity. This 
observation could underlie some paradoxical results of chemotherapeutic 
treatments in patients with peritoneal carcinomatosis [108]. HMGB1 is also 
released by mesothelial cells challenged with asbestos, an event implicated in 
the natural history of malignant mesothelioma [109-113]. Abdominal surgery 
results per se in the release of HMGB1 in the peritoneal cavity. In turn, 
HMGB1 might create a negative loop via the recruitment of inflammatory 
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leukocytes, in particular myeloid derived suppressor cells (MDSC), to promote 
the metastatization of colon cancer cells after surgery [114]. MDSC comprise 
cells phenotypically or morphologically similar to monocytes and cells closer 
to neutrophils [115]. The ability of HMGB1 to influence the metabolism, 
function and interaction of neutrophils with other innate immune cells [116-
118] might be involved in the tumour-supporting action of MSDC. 
In endometriosis, macrophages deliver signals that attract vessels, facilitating 
the survival of ectopic endometrial cells in the relatively hypoxic peritoneal 
cavity [62]. Subpopulations of macrophages are preferentially involved in 
angiogenesis [119, 120]. The best characterized are possibly those that 
express the Tie-2 receptor (TEM or Tie-2-expressing 
monocytes/macrophages), which sustain neo-angiogenesis in a variety of 
experimental tumour models. Circulating monocytes express limited amounts 
of Tie-2 in normal conditions. They up-regulate it after homing to hypoxic 
tissue, where they yield a subset of perivascular macrophages [121-123]. 
The VEGF family and associated receptors and the angiopoietin/Tie-2 
systems connect hormonal levels to vessel remodelling [124-127]. Peritoneal 
macrophages are a source of VEGF and ovarian steroids regulate the 
production of this growth factor [128]. Estrogens act on various macrophage 
signalling pathways, influencing in particular those related to the ability to 
sustain the recruitment of inflammatory cells and the remodelling of inflamed 
tissues, such as mitogen-activated protein kinase, phosphatidylinositide-3-
kinase/protein kinase B and NF-κB. As a consequence, a deregulated 
response to steroids might influence the survival of ectopic endometrial cells 
and promote the neoangiogenesis of the lesions [129, 130]. 
Endometriotic lesions do not contain neoplastic cells. However they share 
with neoplasm features such as unrestrained growth, invasion of adjacent 
tissues, defective apoptosis and sustained inflammatory responses. 
Endometriosis increases the risk of ovarian cancer, in particular invasive low-
grade serous, clear-cell and endometrioid subtypes [131, 132]. As discussed 
above, macrophages are physiologically recruited to injured tissues, where 
they activate the neo-angiogenic switch, sustain resistance to apoptotic stimuli 
and stimulate the proliferation and invasion of precursor cells, in order to 
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prompt tissue regeneration. Macrophages recruited in the endometriotic 
lesions indeed activate neo-angiogenesis, sustain survival and prompt 
proliferation, possibly contributing to the evolution toward atypical 
endometriosis, metaplasia and then borderline or fully malignant ovarian 
cancer [133]. Interference with the recruitment or the function of angiogenic 
macrophages might prove valuable for targeted molecular intervention. 
Inflammation in the peritoneum as a druggable target 
The innate immune response plays a critical role in peritoneal cancers and 
endometriosis [14, 134], as summarized in Figure 3. Phagocyte depletion via 
clodronate treatment reduces neoplastic growth by limiting neoangiogenesis 
in mouse models of carcinomatosis [50, 108], reduces tumour burden, 
invasion and metastasis in a mouse model of mesothelioma [135], and delays 
tumour progression while leaving unaltered ascites formation in an orthotopic 
model of ovarian cancer [104]. Genetic ablation of macrophages in models of 
experimental colorectal cancer results in decreased infiltration by regulatory T 
cells, CCL20 production and tumour growth [136]. 
Endometriotic lesions fail to grow in the absence of macrophages, and 
develop a glandular and stromal architecture, due to impaired vascularization, 
while retaining the ability to adhere to and to infiltrate the serosal membrane 
in a mouse model [72]. Macrophages are critical for the continued growth of 
lesions, which in their absence fail to develop a glandular and stromal 
architecture due to impaired vascularization [72]. When TEMs are depleted, 
vessels and overall lesions are disrupted. TEMs preferentially localize in 
perivascular areas [137], where they provide survival and growth signals to 
endothelial cells and progenitors [138]. In experimental peritoneal 
carcinomatosis, pharmacological HMGB1 targeting resulted in substantial 
anti-neoplastic effects [105].  
The interaction between neoplastic or ectopic cells and immune cells in the 
peritoneal environment is a critical area for drug development. The 
identification of new molecular targets is essential for progress in the 
treatment of these diseases, a largely unmet medical need. 
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